Sfoglia per Relatore
Mostrati risultati da 1 a 9 di 9
CAR T cells therapy: a promising approach to treat cardiac fibrosis
2023/2024 SIMONETTA, CHIARA
Characterization of the molecular mechanism underlying PI3Kgamma-dependent CFTR phosphorylation and stabilization at the plasma membrane
2020/2021 MERGIOTTI, MARCO
Doxorubicin-induced cardiotoxicity: the emerging role of the cGAS-STING pathway
2022/2023 SALATINO, FRANCESCA
Identification and characterization of an optimized PI3Kg-derived peptide for the treatment of airway obstructive diseases
2021/2022 PRONO, GIULIA
Optimization of single-domain antibodies functionalization for lung administration
2020/2021 CAPUTO, ANNALISA
Unraveling the role of immune cells underlying the cardiotoxic effects of Immune Checkpoint Inhibitor Therapies
2021/2022 PRIOLO, REBECCA
Unravelling the role of gene variants in Doxorubicin-Induced Cardiotoxicity
2023/2024 GAVATORTA, GIOVANNI
Unveiling the Metabolic Changes Underlying Doxorubicin-Induced Cardiotoxicity: Insights into Cardiac Lipotoxicity
2023/2024 PRIOLO, REBECCA
Utilizzo di un peptide mimetico della PI3Kγ per ripristinare la localizzazione del CFTR sulla membrana plasmatica
2023/2024 BECCO, VIRGINIA
Mostrati risultati da 1 a 9 di 9
Legenda icone
- file disponibili solo agli amministratori
- nessun file disponibile